Amgen Inc. (BCBA:AMGN)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of ARS 222.03 trillion. The enterprise value is 290.51 trillion.

Market Cap	222.03T
Enterprise Value	290.51T

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Aug 22, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.99M

Valuation Ratios

The trailing PE ratio is 28.15 and the forward PE ratio is 14.24.

PE Ratio	28.15
Forward PE	14.24
PS Ratio	5.34
PB Ratio	25.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.50, with an EV/FCF ratio of 22.99.

EV / Earnings	36.83
EV / Sales	5.85
EV / EBITDA	12.50
EV / EBIT	19.03
EV / FCF	22.99

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 7.57.

Current Ratio	1.31
Quick Ratio	0.82
Debt / Equity	7.57
Debt / EBITDA	3.44
Debt / FCF	5.30
Interest Coverage	3.11

Financial Efficiency

Return on equity (ROE) is 99.14% and return on invested capital (ROIC) is 10.15%.

Return on Equity (ROE)	99.14%
Return on Assets (ROA)	7.51%
Return on Invested Capital (ROIC)	10.15%
Return on Capital Employed (ROCE)	15.93%
Revenue Per Employee	1.49B
Profits Per Employee	281.71M
Employee Count	28,000
Asset Turnover	0.39
Inventory Turnover	1.47

Taxes

In the past 12 months, Amgen has paid 959.32 billion in taxes.

Income Tax	959.32B
Effective Tax Rate	10.84%

Stock Price Statistics

The stock price has increased by +14.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.96%
50-Day Moving Average	13,490.40
200-Day Moving Average	12,126.45
Relative Strength Index (RSI)	52.41
Average Volume (20 Days)	4,771

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.73

Income Statement

In the last 12 months, Amgen had revenue of ARS 41.61 trillion and earned 7.89 trillion in profits. Earnings per share was 14,574.49.

Revenue	41.61T
Gross Profit	28.86T
Operating Income	12.80T
Pretax Income	8.85T
Net Income	7.89T
EBITDA	19.24T
EBIT	12.80T
Earnings Per Share (EPS)	14,574.49

Balance Sheet

The company has 9.57 trillion in cash and 66.98 trillion in debt, giving a net cash position of -57,411.34 billion.

Cash & Cash Equivalents	9.57T
Total Debt	66.98T
Net Cash	-57,411.34B
Net Cash Per Share	n/a
Equity (Book Value)	8.85T
Book Value Per Share	16,444.26
Working Capital	7.46T

Cash Flow

In the last 12 months, operating cash flow was 14.32 trillion and capital expenditures -1,677.91 billion, giving a free cash flow of 12.64 trillion.

Operating Cash Flow	14.32T
Capital Expenditures	-1,677.91B
Free Cash Flow	12.64T
FCF Per Share	n/a

Margins

Gross margin is 69.36%, with operating and profit margins of 30.75% and 18.96%.

Gross Margin	69.36%
Operating Margin	30.75%
Pretax Margin	21.26%
Profit Margin	18.96%
EBITDA Margin	46.25%
EBIT Margin	30.75%
FCF Margin	30.37%

Dividends & Yields

This stock pays an annual dividend of 228.85, which amounts to a dividend yield of 1.59%.

Dividend Per Share	228.85
Dividend Yield	1.59%
Dividend Growth (YoY)	56.95%
Years of Dividend Growth	14
Payout Ratio	75.15%
Buyback Yield	-0.19%
Shareholder Yield	1.40%
Earnings Yield	3.55%
FCF Yield	5.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 3.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	3

Scores

Amgen has an Altman Z-Score of 1.68 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	7